Arterial Hypertension in Aortic Valve Stenosis: A Critical Update

Area of Science:

• Cardiology
• Cardiovascular Medicine
• Clinical Pharmacology

Background:

• Aortic stenosis (AS) is a prevalent valve disease associated with high mortality in symptomatic patients.
• Arterial hypertension (HT) frequently coexists with AS, exacerbating left ventricle remodeling and valve degeneration.
• HT complicates AS severity assessment, potentially leading to underestimation of stenosis.

Purpose of the Study:

• To review available studies on managing hypertension in patients with aortic stenosis.
• To guide antihypertensive treatment strategies in the context of coexisting HT and AS.
• To evaluate the safety and efficacy of different antihypertensive drug classes in this patient population.

Main Methods:

• Systematic review of existing literature on hypertension and aortic stenosis.
• Analysis of pharmacokinetic and pharmacodynamic profiles of antihypertensive agents.
• Evaluation of clinical evidence regarding drug safety and efficacy in HT/AS patients.

Main Results:

• Several antihypertensive drugs are now considered safe and effective for blood pressure reduction in HT/AS patients.
• RAAS inhibitors and beta-blockers offer benefits in specific patient subgroups.
• Certain agents like calcium channel blockers are deemed unsafe, while others (PDE5i, MRA, sodium nitroprusside) present handling challenges.

Conclusions:

• Antihypertensive treatment in AS patients with HT is feasible and beneficial with careful drug selection.
• Understanding drug-specific profiles is key to optimizing treatment and avoiding adverse outcomes.
• This review provides a guide for clinicians managing complex cardiovascular conditions.